Category: News

Beyond Celiac Town Hall: Related Conditions Q&A with Stefano Guandalini, MD

Beyond Celiac is hosting this program July 28, 2022 – 3 PM ET. Register at their website.

From their website:

This Q&A session will feature renowned celiac disease expert Dr. Guandalini, professor emeritus at the University of Chicago and the founder of the University of Chicago Celiac Disease Center. Dr. Guandalini’s clinical and research efforts have greatly influenced the way celiac disease is diagnosed and treated today. His work contributed to the revision of 20-year-old guidelines for diagnosing celiac disease.

Dr. Guandalini has been ranked among America’s “Best Doctors” since 2008. In 2012, he received the prestigious title of “Master of Pediatrics” from the Italian Society of Pediatrics. In 2016, he published Textbook of Pediatric Gastroenterology, Hepatology and Nutrition.

Dr. Guandalini is also the medical advisor for Beyond Celiac partner, and sponsor of this Town Hall, imaware™.

In this Q&A, Dr. Guandalini will focus on answering questions about conditions and co-morbidities that are commonly seen alongside celiac disease. You can submit your questions when you sign up for the event—please do not send test results or ask Dr. Guandalini to diagnose you with any condition.

Register at the Beyond Celiac website.

GLUTEN DUDE APP

app@glutendude.com

The Gluten Dude App: For a Better Gluten-free Life

“Eating out with celiac disease is stressful. The Gluten Dude app lists only restaurants that have been highly recommended and personally vetted, so you can spend less time worrying and more time enjoying yourself. “

GET A LIFETIME SUBSCRIPTION TO THE GLUTEN DUDE APP!

!This limited time offer ends June 22!

NYT Article: Are We Close to a Treatment for Celiac Disease?

According to this New York Times article published 6/1/22, the Celiac Disease Foundation says that there are currently 24 potential therapies at various stages of development.

Of the potential therapies in development, the one furthest along — currently being tested in a Phase 3 trial — is a drug called larazotide, which decreases the porosity of the small intestine and has shown promise from earlier trials. In a best-case scenario, larazotide could be approved and on the market within two to three years, said Dr. Fasano, who was involved with the development of the drug and has a financial interest in it.

I first heard Dr. Fasano speak nearly 15 years ago when he said that a drug to treat Celiac Disease would be available in 5 years. That was 10 years ago. Hope he is more accurate with his current prediction.